tiprankstipranks
Innate Pharma SA (IPHYF)
OTHER OTC:IPHYF
US Market
IPHYF
Innate Pharma SA
RESEARCH TOOLSreports

Innate Pharma SA (IPHYF) Balance Sheet

27 Followers

Innate Pharma SA Balance Sheet

Innate Pharma SA's total assets for Q4 2025 were €62.72M, a decrease of -32.51% from the previous quarter. IPHYF total liabilities were €84.42M for the fiscal quarter, a -3.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
€ 62.72M€ 111.06M€ 184.19M€ 207.86M€ 267.50M
Total Liabilities
€ 84.42M€ 102.22M€ 132.29M€ 153.71M€ 160.06M
Total Equity Gross Minority
€ -21.70M€ 8.83M€ 51.90M€ 54.15M€ 107.44M
Other Metrics
Currency in EUR

Innate Pharma SA Debt to Assets